An inclusion complex is not simply diluted azelaic acid
The host cyclodextrin, preparation method, active loading and degree of inclusion influence apparent solubility, release and sensory behavior. Commercial grades with 10%, 40% or 60% azelaic-acid content should be compared on delivered active, water compatibility and formulation performance—not just powder price.
A higher nominal loading does not automatically give the best clear or stable system. The buyer should evaluate pH, ionic strength, solvent package, other actives and processing sequence.
Define the critical quality attributes
Request active assay, host identity, free versus complexed azelaic acid where available, water, particle size, solubility or dispersibility test, pH, microbial limits and stability. Odor, color and release behavior may also matter. The complex should be tested against free azelaic acid and the relevant formulation control.
Claims and use levels still require market review
Improved formulation handling does not automatically authorize therapeutic or cosmetic claims. State the intended product type, target active level, market, pH and process. Confirm cosmetic or pharmaceutical grade, documentation, packaging and storage, then complete finished-formula stability, compatibility, safety and efficacy evaluation.